India Establishes Three-Trial Maximum for Investigators

Drug Industry Daily
A A
Investigators participating in clinical trials in India must limit their work to no more than three trials at any given time. That’s one of mandates laid out in 14 finalized regulations issued July 3 by the Central Drugs Standard Control Organization.

To View This Article:

Login

Subscribe To Drug Industry Daily